These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
384 related articles for article (PubMed ID: 25659889)
21. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Novak V; Milberg W; Hao Y; Munshi M; Novak P; Galica A; Manor B; Roberson P; Craft S; Abduljalil A Diabetes Care; 2014; 37(3):751-9. PubMed ID: 24101698 [TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease. Stein MS; Scherer SC; Ladd KS; Harrison LC J Alzheimers Dis; 2011; 26(3):477-84. PubMed ID: 21694461 [TBL] [Abstract][Full Text] [Related]
23. Outcomes and clinical implications of intranasal insulin administration to the central nervous system. Santiago JCP; Hallschmid M Exp Neurol; 2019 Jul; 317():180-190. PubMed ID: 30885653 [TBL] [Abstract][Full Text] [Related]
24. An assessment of the central disposition of intranasally administered insulin lispro in the cerebrospinal fluid of healthy volunteers and beagle dogs. Lowe S; Sher E; Wishart G; Jackson K; Yuen E; Brittain C; Fong SC; Clarke DO; Landschulz WH Drug Deliv Transl Res; 2017 Feb; 7(1):11-15. PubMed ID: 27553192 [TBL] [Abstract][Full Text] [Related]
25. Intranasal Neuropeptide Administration To Target the Human Brain in Health and Disease. Spetter MS; Hallschmid M Mol Pharm; 2015 Aug; 12(8):2767-80. PubMed ID: 25880274 [TBL] [Abstract][Full Text] [Related]
27. Testosterone replacement attenuates cognitive decline in testosterone-deprived lean rats, but not in obese rats, by mitigating brain oxidative stress. Pintana H; Pongkan W; Pratchayasakul W; Chattipakorn N; Chattipakorn SC Age (Dordr); 2015 Oct; 37(5):84. PubMed ID: 26277724 [TBL] [Abstract][Full Text] [Related]
28. Intranasal insulin therapy reverses hippocampal dendritic injury and cognitive impairment in a model of HIV-associated neurocognitive disorders in EcoHIV-infected mice. Kim BH; Kelschenbach J; Borjabad A; Hadas E; He H; Potash MJ; Nedelcovych MT; Rais R; Haughey NJ; McArthur JC; Slusher BS; Volsky DJ AIDS; 2019 May; 33(6):973-984. PubMed ID: 30946151 [TBL] [Abstract][Full Text] [Related]
29. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease. O' Neill C Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275 [TBL] [Abstract][Full Text] [Related]
30. Hippocampal calcium dysregulation at the nexus of diabetes and brain aging. Thibault O; Anderson KL; DeMoll C; Brewer LD; Landfield PW; Porter NM Eur J Pharmacol; 2013 Nov; 719(1-3):34-43. PubMed ID: 23872402 [TBL] [Abstract][Full Text] [Related]
31. Central activation of PPAR-gamma ameliorates diabetes induced cognitive dysfunction and improves BDNF expression. Kariharan T; Nanayakkara G; Parameshwaran K; Bagasrawala I; Ahuja M; Abdel-Rahman E; Amin AT; Dhanasekaran M; Suppiramaniam V; Amin RH Neurobiol Aging; 2015 Mar; 36(3):1451-61. PubMed ID: 25510319 [TBL] [Abstract][Full Text] [Related]
32. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Stockhorst U; de Fries D; Steingrueber HJ; Scherbaum WA Physiol Behav; 2004 Oct; 83(1):47-54. PubMed ID: 15501490 [TBL] [Abstract][Full Text] [Related]
33. Obese men respond to cognitive but not to catabolic brain insulin signaling. Hallschmid M; Benedict C; Schultes B; Born J; Kern W Int J Obes (Lond); 2008 Feb; 32(2):275-82. PubMed ID: 17848936 [TBL] [Abstract][Full Text] [Related]
34. Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer's disease. Solas M; Aisa B; Tordera RM; Mugueta MC; Ramírez MJ Biochim Biophys Acta; 2013 Dec; 1832(12):2332-9. PubMed ID: 24090692 [TBL] [Abstract][Full Text] [Related]
35. Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. Kullmann S; Heni M; Hallschmid M; Fritsche A; Preissl H; Häring HU Physiol Rev; 2016 Oct; 96(4):1169-209. PubMed ID: 27489306 [TBL] [Abstract][Full Text] [Related]
37. Neuroprotective role of Indirubin-3'-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice. Sharma S; Taliyan R Biochem Biophys Res Commun; 2014 Oct; 452(4):1009-15. PubMed ID: 25234596 [TBL] [Abstract][Full Text] [Related]
38. Insulin resistance in the brain: an old-age or new-age problem? Williamson R; McNeilly A; Sutherland C Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336 [TBL] [Abstract][Full Text] [Related]
39. Intranasal Insulin Transport is Preserved in Aged SAMP8 Mice and is Altered by Albumin and Insulin Receptor Inhibition. Rhea EM; Humann SR; Nirkhe S; Farr SA; Morley JE; Banks WA J Alzheimers Dis; 2017; 57(1):241-252. PubMed ID: 28222522 [TBL] [Abstract][Full Text] [Related]
40. Effect of intranasal insulin on cognitive function: a systematic review. Shemesh E; Rudich A; Harman-Boehm I; Cukierman-Yaffe T J Clin Endocrinol Metab; 2012 Feb; 97(2):366-76. PubMed ID: 22162476 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]